Cepas probióticas para usar en la mejora del sistema nervioso entérico

Composición que comprende al menos una cepa de bacterias, seleccionada del grupo que consiste en - DN_156_0032 (CNCM I-4321 presentada el 19 de mayo de 2010), - DN_121_0304 (CNCM I-4318 presentada el 19 de mayo de 2010), - DN_116_047 (CNCM I-4317 presentada el 19 de mayo de 2010), - DN_154_0067 (CNC...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Legrain-Raspaud, Sophie, Capronnier, Sandrine, Degivry, Marie-Christine, Lesic, Biliana, Neunlist, Michel, Chambaud, Isabelle, Grompone, Gianfranco, Smokvina, Tamara
Format:	Patent
Sprache:	spa
Schlagworte:	DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MAKING THEREOF MEDICAL OR VETERINARY SCIENCE MILK OR CHEESE SUBSTITUTES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Legrain-Raspaud, Sophie Capronnier, Sandrine Degivry, Marie-Christine Lesic, Biliana Neunlist, Michel Chambaud, Isabelle Grompone, Gianfranco Smokvina, Tamara
description	Composición que comprende al menos una cepa de bacterias, seleccionada del grupo que consiste en - DN_156_0032 (CNCM I-4321 presentada el 19 de mayo de 2010), - DN_121_0304 (CNCM I-4318 presentada el 19 de mayo de 2010), - DN_116_047 (CNCM I-4317 presentada el 19 de mayo de 2010), - DN_154_0067 (CNCM I-4320 presentada el 19 de mayo de 2010), y - DN_119_0118 (CNCM I-4279 presentada el 25 de febrero de 2010), para su uso en: A) aumento de los niveles de péptido intestinal vasoactivo (VIP) del sistema nervioso entérico, o B) aumento de los niveles de neuronas inmunorreactivas a colina acetil transferasa (ChAT) del sistema nervioso entérico, o C) reducción de los niveles de ChAT del sistema nervioso entérico. The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2744274TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2744274TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2744274TT33</originalsourceid><addsrcrecordid>eNrjZPBwTi1ILFYoKMpPyjy8uSQzGcRJLEpUKC1OLFJIzVPISVTITc3KB4qkpOYoFGcWl6TmJirkpRaVZeYX5wNVlBxeWZSZnM_DwJqWmFOcyguluRkU3VxDnD10Uwvy41OLCxKTU_NSS-Jdg43MTUyAOCTE2JgYNQA3NzX8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cepas probióticas para usar en la mejora del sistema nervioso entérico</title><source>esp@cenet</source><creator>Legrain-Raspaud, Sophie ; Capronnier, Sandrine ; Degivry, Marie-Christine ; Lesic, Biliana ; Neunlist, Michel ; Chambaud, Isabelle ; Grompone, Gianfranco ; Smokvina, Tamara</creator><creatorcontrib>Legrain-Raspaud, Sophie ; Capronnier, Sandrine ; Degivry, Marie-Christine ; Lesic, Biliana ; Neunlist, Michel ; Chambaud, Isabelle ; Grompone, Gianfranco ; Smokvina, Tamara</creatorcontrib><description>Composición que comprende al menos una cepa de bacterias, seleccionada del grupo que consiste en - DN_156_0032 (CNCM I-4321 presentada el 19 de mayo de 2010), - DN_121_0304 (CNCM I-4318 presentada el 19 de mayo de 2010), - DN_116_047 (CNCM I-4317 presentada el 19 de mayo de 2010), - DN_154_0067 (CNCM I-4320 presentada el 19 de mayo de 2010), y - DN_119_0118 (CNCM I-4279 presentada el 25 de febrero de 2010), para su uso en: A) aumento de los niveles de péptido intestinal vasoactivo (VIP) del sistema nervioso entérico, o B) aumento de los niveles de neuronas inmunorreactivas a colina acetil transferasa (ChAT) del sistema nervioso entérico, o C) reducción de los niveles de ChAT del sistema nervioso entérico. The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.</description><language>spa</language><subject>DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE ; FOODS OR FOODSTUFFS ; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J ; HUMAN NECESSITIES ; HYGIENE ; MAKING THEREOF ; MEDICAL OR VETERINARY SCIENCE ; MILK OR CHEESE SUBSTITUTES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT ; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200224&DB=EPODOC&CC=ES&NR=2744274T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200224&DB=EPODOC&CC=ES&NR=2744274T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Legrain-Raspaud, Sophie</creatorcontrib><creatorcontrib>Capronnier, Sandrine</creatorcontrib><creatorcontrib>Degivry, Marie-Christine</creatorcontrib><creatorcontrib>Lesic, Biliana</creatorcontrib><creatorcontrib>Neunlist, Michel</creatorcontrib><creatorcontrib>Chambaud, Isabelle</creatorcontrib><creatorcontrib>Grompone, Gianfranco</creatorcontrib><creatorcontrib>Smokvina, Tamara</creatorcontrib><title>Cepas probióticas para usar en la mejora del sistema nervioso entérico</title><description>Composición que comprende al menos una cepa de bacterias, seleccionada del grupo que consiste en - DN_156_0032 (CNCM I-4321 presentada el 19 de mayo de 2010), - DN_121_0304 (CNCM I-4318 presentada el 19 de mayo de 2010), - DN_116_047 (CNCM I-4317 presentada el 19 de mayo de 2010), - DN_154_0067 (CNCM I-4320 presentada el 19 de mayo de 2010), y - DN_119_0118 (CNCM I-4279 presentada el 25 de febrero de 2010), para su uso en: A) aumento de los niveles de péptido intestinal vasoactivo (VIP) del sistema nervioso entérico, o B) aumento de los niveles de neuronas inmunorreactivas a colina acetil transferasa (ChAT) del sistema nervioso entérico, o C) reducción de los niveles de ChAT del sistema nervioso entérico. The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.</description><subject>DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE</subject><subject>FOODS OR FOODSTUFFS</subject><subject>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MAKING THEREOF</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>MILK OR CHEESE SUBSTITUTES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</subject><subject>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBwTi1ILFYoKMpPyjy8uSQzGcRJLEpUKC1OLFJIzVPISVTITc3KB4qkpOYoFGcWl6TmJirkpRaVZeYX5wNVlBxeWZSZnM_DwJqWmFOcyguluRkU3VxDnD10Uwvy41OLCxKTU_NSS-Jdg43MTUyAOCTE2JgYNQA3NzX8</recordid><startdate>20200224</startdate><enddate>20200224</enddate><creator>Legrain-Raspaud, Sophie</creator><creator>Capronnier, Sandrine</creator><creator>Degivry, Marie-Christine</creator><creator>Lesic, Biliana</creator><creator>Neunlist, Michel</creator><creator>Chambaud, Isabelle</creator><creator>Grompone, Gianfranco</creator><creator>Smokvina, Tamara</creator><scope>EVB</scope></search><sort><creationdate>20200224</creationdate><title>Cepas probióticas para usar en la mejora del sistema nervioso entérico</title><author>Legrain-Raspaud, Sophie ; Capronnier, Sandrine ; Degivry, Marie-Christine ; Lesic, Biliana ; Neunlist, Michel ; Chambaud, Isabelle ; Grompone, Gianfranco ; Smokvina, Tamara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2744274TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2020</creationdate><topic>DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE</topic><topic>FOODS OR FOODSTUFFS</topic><topic>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MAKING THEREOF</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>MILK OR CHEESE SUBSTITUTES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</topic><topic>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Legrain-Raspaud, Sophie</creatorcontrib><creatorcontrib>Capronnier, Sandrine</creatorcontrib><creatorcontrib>Degivry, Marie-Christine</creatorcontrib><creatorcontrib>Lesic, Biliana</creatorcontrib><creatorcontrib>Neunlist, Michel</creatorcontrib><creatorcontrib>Chambaud, Isabelle</creatorcontrib><creatorcontrib>Grompone, Gianfranco</creatorcontrib><creatorcontrib>Smokvina, Tamara</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Legrain-Raspaud, Sophie</au><au>Capronnier, Sandrine</au><au>Degivry, Marie-Christine</au><au>Lesic, Biliana</au><au>Neunlist, Michel</au><au>Chambaud, Isabelle</au><au>Grompone, Gianfranco</au><au>Smokvina, Tamara</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cepas probióticas para usar en la mejora del sistema nervioso entérico</title><date>2020-02-24</date><risdate>2020</risdate><abstract>Composición que comprende al menos una cepa de bacterias, seleccionada del grupo que consiste en - DN_156_0032 (CNCM I-4321 presentada el 19 de mayo de 2010), - DN_121_0304 (CNCM I-4318 presentada el 19 de mayo de 2010), - DN_116_047 (CNCM I-4317 presentada el 19 de mayo de 2010), - DN_154_0067 (CNCM I-4320 presentada el 19 de mayo de 2010), y - DN_119_0118 (CNCM I-4279 presentada el 25 de febrero de 2010), para su uso en: A) aumento de los niveles de péptido intestinal vasoactivo (VIP) del sistema nervioso entérico, o B) aumento de los niveles de neuronas inmunorreactivas a colina acetil transferasa (ChAT) del sistema nervioso entérico, o C) reducción de los niveles de ChAT del sistema nervioso entérico. The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	spa
recordid	cdi_epo_espacenet_ES2744274TT3
source	esp@cenet
subjects	DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MAKING THEREOF MEDICAL OR VETERINARY SCIENCE MILK OR CHEESE SUBSTITUTES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
title	Cepas probióticas para usar en la mejora del sistema nervioso entérico
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T01%3A06%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Legrain-Raspaud,%20Sophie&rft.date=2020-02-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2744274TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true